Drug firm Elder Pharmaceuticals today said its promoters have pledged 10 lakh more shares of the company, taking the quantum of such shares of the firm to 9.4%.
Semit Pharmaceuticals Chemicals Pvt Ltd, a part of the promoter group has pledged ten lakh shares of the company on September 19, 2011, Elder Pharmaceuticals said in a filing to the BSE.
While the company did not disclose the financial details of the transaction, based on the closing share price of Rs 375.65 per share on the BSE on the day, the shares are worth around Rs 37.56 crore.
Post the latest transaction, the total number of pledged shares stood at 19.43 lakh, aggregating 9.46% stake in the company, the filing added.
Shares of Elder Pharmaceuticals today closed at Rs 379.85 on BSE, up 1.14% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app